Philip E.J. Sanderson

Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs

Jennifer Kouznetsova, Wei Sun, Carles Martínez‐Romero et al. · Emerging Microbes & Infections · 2014 · 240 citations · Full text

Drug Target, Ebola Infection, Medicine +14

The phenyldimethylsilyl group as a masked hydroxy group

Ian Fleming, Rolf Henning, David C. Parker et al. · Journal of the Chemical Society Perkin Transactions 1 · 1995 · 238 citations

Chemical Engineering, Novel Organocatalysts, Engineering +8

A one-pot conversion of the phenyldimethylsilyl group into a hydroxyl group

Ian Fleming, Philip E.J. Sanderson · Tetrahedron Letters · 1987 · 205 citations

Organic Material Chemistry, Engineering, Hydroxyl Group +6

The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents

P.H. Hutson, Eleftheria N. Finger, Brian C. Magliaro et al. · Neuropharmacology · 2011 · 139 citations

Synaptic Plasticity, Medicine, Synaptic Transmission +9

An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19

Jonathan H. Shrimp, Stephen C. Kales, Philip E.J. Sanderson et al. · ACS Pharmacology & Translational Science · 2020 · 129 citations · Full text